基于酸的衍生物的分子设计作为Helicobacter pylori的尿酶抑制剂
Na Wang1, Xiaoyan Wu1, Jianhuai Liang1
1College of Materials and Energy, South China Agricultural University, Guangzhou, 510630, China.
Molecular diversity
|July 17, 2024
概括
这项研究确定了抑制Helicobacter pylori尿酶的关键分子结构,这是胃癌治疗的目标. 设计和模拟了新型化合物,其中一种作为候选药物显示出希望.
科学领域:
- 药用化学 医学化学
- 计算化学计算化学
- 药物发现 药物发现 药物发现
背景情况:
- 杆菌是胃癌的主要原因.
- 细菌的尿酶酶产生氨,有助于其殖民.
- 抑制尿酶是一种对抗H. pylori感染的策略.
研究的目的:
- 为了确定增强尿酶抑制的结构特征.
- 设计新型,高活性尿酶抑制剂.
- 通过计算来评估潜在的药物候选者.
主要方法:
- 开发了一个集体机器学习模型 (R2=0.761) 来预测化合物活动.
- 分析了化学空间,分子支架和物理化学特性.
- 利用分子动态模拟来评估活性部位中的化合物稳定性.
主要成果:
- 突出了酸组和环对活性的重要性.
- 确定酸衍生物上的特定环替代剂对于增强至关重要.
- 设计了11种新的酸衍生物 (mol1-11).
- 化合物mol9证明了尿酶活性部位的稳定.
结论:
- 结构性见解指导了强大的H. pylori尿酶抑制剂的设计.
- 化合物mol9是进一步开发的有希望的候选物.
- 对mol9.9进行进一步的体外,体内和临床试验是有必要的.
相关概念视频
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
365
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
365
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
345
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
345
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
415
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
415
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
339
In the complex environment of the gastric lumen, excessive acid secretion can lead to the formation or worsening of ulcers within the delicate mucosal layer. Antacids, such as sodium bicarbonate and calcium carbonate, provide relief by neutralizing this acid, transforming it into harmless salt and water. This neutralization process raises the gastric pH from a highly acidic level of 1 to a more basic 3-4, reducing the acidity within the stomach.
However, this neutralization reaction between...
However, this neutralization reaction between...
339
Basicity of Heterocyclic Aromatic Amines
5.9K
Heterocyclic amines, where the N atom is a part of an alicyclic system, are similar in basicity to alkylamines. Interestingly, the heterocyclic amine having a nitrogen atom as part of an aromatic ring has much less basicity than its corresponding alicyclic counterpart. For this reason, as presented in Figure 1, piperidine (pKb = 2.8) is significantly more basic than pyridine (pKb = 8.8).
5.9K
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
390
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
390


